Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Nik Newland"'
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-11 (2024)
Abstract Background As well as being associated with serious negative health outcomes, smoking has been reported to have an array of physiological and psychological effects, including effects on mood and cognitive function. Post-cessation, loss of su
Externí odkaz:
https://doaj.org/article/b2275683f3b04b6a9c5b5eea4bde0b19
Autor:
Oscar M. Camacho, Andrew Hedge, Frazer Lowe, Nik Newland, Nathan Gale, Mike McEwan, Christopher Proctor
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Tobacco harm reduction strategies aim to substitute smoking with potentially reduced risk products (PRRPs) such as e-cigarettes and tobacco-heating products (THPs). The health benefits of switching from smoking to PRRPs is unknown. A randomised contr
Externí odkaz:
https://doaj.org/article/1fd7852ff53a4d9a821856021aea2177
Autor:
Christopher Proctor, Frazer Lowe, James Murphy, George Hardie, James K. Ebajemito, Mike McEwan, Nathan Gale, Nik Newland, Oscar M. Camacho
Publikováno v:
Internal and Emergency Medicine
Tobacco heating products (THPs) are a potentially safer alternative to combustible cigarette smoking. Through continued use, THPs may reduce smoking-related disease risk, whilst maintaining the sensorial experience and nicotine delivery sought by smo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae32bd540726f80481962ed70d869ab8
https://doi.org/10.1007/s11739-019-02090-8
https://doi.org/10.1007/s11739-019-02090-8
Autor:
Nathan Gale, Frazer Lowe, Christopher Proctor, Oscar M. Camacho, Mike McEwan, Nik Newland, Andrew Hedge
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Tobacco harm reduction strategies aim to substitute smoking with potentially reduced risk products (PRRPs) such as e-cigarettes and tobacco-heating products (THPs). The health benefits of switching from smoking to PRRPs is unknown. A randomised contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c884abe3cf7259877fe93ccf4e9ae0f
https://doi.org/10.1016/j.conctc.2020.100535
https://doi.org/10.1016/j.conctc.2020.100535
Publikováno v:
Toxicology in Vitro. 25:922-929
Background The respiratory tract is the primary route of exposure to inhaled toxicants such as environmental pollutants and tobacco smoke. Metabolic activation of xenobiotics is a contributor to the onset of lung diseases. Enzymes such as CYP1A1/1B1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b61307c4faefb19f4c03326834c6e7
https://doi.org/10.1016/j.tiv.2011.02.014
https://doi.org/10.1016/j.tiv.2011.02.014
Autor:
Don Graff, Frazer Lowe, Alison Eldridge, Oscar M. Camacho, Ermioni Papadopoulou, Christopher J. Shepperd, Ingo Meyer, Linsey E. Haswell, Nik Newland, Christopher Proctor
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 72(2)
Background Development of cigarettes that reduce exposure to harmful smoke constituents is a suggested tobacco harm reduction strategy, but robust methods for measurement of change are required. We investigated whether changes in biomarkers of exposu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cedab1d289039b03d608dc9eb5cfaaee
https://pubmed.ncbi.nlm.nih.gov/25957570
https://pubmed.ncbi.nlm.nih.gov/25957570
Publikováno v:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 19(5)
Context: Biomarkers of biological effect (BOBE) have been proposed as potential tools to assess tobacco product use, toxicity and disease risk.Objective: To determine if candidate BOBE can distinguish between smokers, never-smokers and former smokers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f78ffa3b037c7893379718e70d162917
https://pubmed.ncbi.nlm.nih.gov/24854418
https://pubmed.ncbi.nlm.nih.gov/24854418
Autor:
Nik Newland, Audrey Richter
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 22(7)
The aim of this study was to investigate an in vitro lung epithelial model for assessment of potential inhalation toxicity. The selected NCI-H292 lung carcinoma cell line is sensitive to cigarette smoke, responds in a similar manner to primary human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7bf5d3f5fe8605d1e830e51fbfba90a
https://pubmed.ncbi.nlm.nih.gov/18684396
https://pubmed.ncbi.nlm.nih.gov/18684396
Autor:
Green, Harry J.1 (AUTHOR) harry_green@bat.com, O'Shea, Olivia K.1 (AUTHOR), Cotter, Jack1 (AUTHOR), Philpott, Helen L.2 (AUTHOR), Newland, Nik1 (AUTHOR)
Publikováno v:
Harm Reduction Journal. 4/6/2024, Vol. 21 Issue 1, p1-11. 11p.
Publikováno v:
BMC Public Health
Despite universal acceptance that smoking is harmful, a substantial number of adults continue to smoke. The development of potential reduced exposure products (more recently termed modified risk tobacco products) has been suggested as a way to reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22123ec6e8d44444d82b8072e2a6c2c5